Mostrar el registro sencillo

dc.contributor.authorRiancho Zarrabeitia, Javier 
dc.contributor.authorPaz Fajardo, Lucía
dc.contributor.authorLópez de Munaín, Adolfo
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2021-07-08T10:15:05Z
dc.date.available2021-07-08T10:15:05Z
dc.date.issued2021-03
dc.identifier.issn0007-1188
dc.identifier.issn1476-5381
dc.identifier.urihttp://hdl.handle.net/10902/21967
dc.description.abstractAmyotrophic lateral sclerosis (ALS) is the most common motor neuron neurodegenerative disease. Although it has been classically considered as a disease limited to the motor system, there is increasing evidence for the involvement of other neural and non-neuronal systems. In this review, we will discuss currently existing literature regarding the involvement of the sensory system in ALS. Human studies have reported intradermic small fibre loss, sensory axonal predominant neuropathy, as well as somatosensory cortex hyperexcitability. In line with this, ALS animal studies have demonstrated the involvement of several sensory components. Specifically, they have highlighted the impairment of sensory?motor networks as a potential mechanism for the disease. The elucidation of these ?non-motor? systems involvement, which might also be part of the degeneration process, should prompt the scientific community to re-consider ALS as a pure motor neuron disease, which may in turn result in more holistic research approaches.es_ES
dc.format.extent12 p.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rights© British Pharmacological Society. Published by Wiley.""This is the pre-peer reviewed version of the following article: Riancho J, Paz-Fajardo L, López deMunaín A. Clinical and preclinical evidence of somatosensoryinvolvement in amyotrophic lateral sclerosis. Br J Pharmacol.2021;178:1257-1268, which has been published in final form at https://doi.org/10.1111/bph.15202. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions."es_ES
dc.sourceBr J Pharmacol. 2021;178:1257-1268.es_ES
dc.subject.otherAmyotrophic lateral sclerosises_ES
dc.subject.otherSensory disorderses_ES
dc.subject.otherClinicales_ES
dc.subject.otherPreclinicales_ES
dc.titleClinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1111/bph.15202es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1111/bph.15202
dc.type.versionacceptedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo